Posted by Michael Wonder on 11 Feb 2019
Humana executives say Trump's drug rebate proposal would raise premiums, restrict consumer choice
8 February 2019 - Trump's new plan to lower drug costs would raise premiums for the broader populations, according to insurance executives.
The Trump administration's plan to force insurers to pass on drugmaker discounts to seniors at the pharmacy counter would upend the market and raise consumer premiums in the end, health insurance executives warned investors this week.
"Our perspective is that that would raise premiums for the broader populations. And that in of itself I think creates some disruption in the marketplace that we have to think through," Humana Chief Financial Officer Brian Kane told investors on a call discussing the company's earnings Wednesday.
